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Abstract
Rising healthcare complications due to fungal infections increase the importance of efficient specimen collection and mainte-
nance systems for correct identification and diagnosis. The CLSI M40-A2 protocol provides guidelines for laboratories assessing
quality of medical transport devices, including swab transport systems (STS). This study assessed the efficiency of the Sigma
Transwab® foam and flock swab in recovering andmaintaining viability of differentCandida spp. includingC. auris, in different
test conditions. Both swab types recovered and maintained viability of all Candida spp. with greater CFU at room temperature
after incubation (24 and 48 h) in comparison with swabs maintained at 4 °C.
Keywords Swabs .Candida .C. auris . Sigma Transwab®
Introduction
Invasive fungal diseases are a major global health problem
with mortality rates between 30 and 90% and a large propor-
tion of these diseases caused by of Aspergillus, Cryptococcus,
Candida, or Pneumocystis [1]. Candida spp. have been iden-
tified as a leading cause of pathogenic diseases, with candidi-
asis known to affect more than a quarter of a million patients
worldwide annually [2]. This increase in opportunistic fungal
pathogens can be linked to several factors including chemo-
therapy, transplant situations which result in an increase in
immunocompromised patients [3]. One species of Candida
that is of particular concern is C. auris. Since the first report
of C. auris in 2009 [4], there have been concerns of rapid
spread across the globe [5]; misidentification with other
Candida spp. [6–9]; seriousness of associated infections in-
cluding reports of isolation from the bloodstream, urinary
tract, ear canal, wounds, heart muscle and bone [10]; high
mortality rate, related to bloodstream infections [10–12]; and
its antifungal resistance [6, 13].
Rapid and efficient isolation and identification of infectious
agents are paramount to successful treatment. Medical trans-
port devices, particularly swab transport systems (STS), have
been used in clinical and laboratory diagnosis and are often
used for their low cost, ease of use and ability to maintain
microorganism viability over extended periods of time [14].
The Clinical and Laboratory Standards Institute (CLSI) M40-
A2 is an approved standard which outlines testing procedures
for liquid transport systems and provides manufacturers and
end-users with a criteria for compliance [15]. This standard
focuses on transport and collection devices and recovery of
specimen, focuses largely on bacteria and only identifies
yeasts for quality control of urine transport systems. Thus, it
is important to assess and compare efficiency and effective-
ness of swabs and collection devices in maintaining and re-
covering the integrity of pathogenic yeast specimen. In the
study by Gizzie and Adukwu [14], the authors showed that
both flock and foam Sigma Transwab®, swab types, were
efficient at recovering and maintaining the recommended or-
ganisms in the M40-A2 standard including the difficult path-
ogen Neisseria gonorrhoea. The focus of this current study
was to assess and compare these two swab types, Sigma
Transwab® foam and flocked swab, for maintenance of via-
bility and recovery of different Candida spp., including
C. auris in vitro. This investigation is important as transport,
maintenance and recovery of clinically important fungal
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pathogens are of relevance to medical and clinical laboratories
and to ensure accuracy of diagnosis.
Methods
The CLSI M40-A2 protocol was used with some minor adapta-
tions. The STS used in this study were both manufactured by
Medical Wire and Equipment (MWE; Corsham, UK) and in-
cluded their Sigma Transwab® foam (MW176S) and Sigma
Transwab® Purflock® (MW176PF); both swab types are rec-
ommended for use for wound, skin and throat and utilise a liquid
amies–carrying media. The MW176S employs a cellular foam
bud, while the MW176PF employs a flocked fibre tip. Candida
spp. used in this study include C. aurisNCPF 8971, C. albicans
NCPF 3179, C. tropicalis NCPF 3111, C. parapsilosis ATCC
22019 and C. glabrata ATCC 2001. Smears on microscope
slides were produced for each species of Candida, and a
Gramme stain was performed. Candida spp. stored on
microbank beads at − 80 °C were grown on Sabouraud
Dextrose Agar (SDA; EO Labs, Bonnybridge, UK) at 30 °C
for 48 h and used to inoculate 0.85% physiological saline
(OXOID, Basingstoke, UK) until turbidity reached McFarland
Standard 0.5 (OD625nm 0.08–0.1) with a final working dilutions
of 104 and 103 CFU/ml, with 100 μl aliquots dispensed in trip-
licates into a 96-well plate. The swabs were then immersed in the
aliquots, and the dilutions were absorbed for a period of for 10 s
after which the swabs were placed in the transport medium and
maintained at either room temperature (RT) or 4 °C for 0, 24 and
48 h (T0/T24/T48). The swabs were removed from each well
containing the swab/aliquot, rolled on the agar medium (SDA
agar) and incubated at 30 °C for 48 h according to the CLSI
M40-A2 standard. Following the incubation period, the colonies
were enumerated and CFU values determined. The M40-A2
standard indicates that using the roll plate method, the enumer-
ated counts should be ≥ 5 CFU after the specified holding period
for specimen held at RT or at 4 °C,when the dilution is compared
with the counts from T0 for the STS to be acceptable.
Results
Results from Gram staining procedure showed that all
Candida spp. presented the Gram-positive appearance with
typical round/oval budding morphology. There were no dif-
ferences observed with the swab types in the shape and
Table 1 Qualitative results of bacterial recovery of Candida spp. isolated from the Sigma Transwab® foam (MW176S) and Sigma Transwab®
Purflock® (MW176PF) at room temperature and at 4 °C. Values are expressed as mean CFU of three replicates (n = 3)
Organism Swab Temp. Dilution 10−2 Dilution 10−3
0 h 24 h 48 h Compliance 0 h 24 h 48 h Compliance
Candida auris NCPF 8971 Foam RT TNTC TNTC TNTC ✓ 51 50 TNTC ✓
Foam 4 °C TNTC 179 183 ✓ 51 16 20 ✓
Purflock RT TNTC TNTC TNTC ✓ 35 55 TNTC ✓
Purflock 4 °C TNTC TNTC 208 ✓ 35 43 29 ✓
Candida albicans NCPF 3179 Foam RT 164 TNTC TNTC ✓ 14 117 255 ✓
Foam 4 °C 164 153 134 ✓ 14 14 13 ✓
Purflock RT 176 TNTC TNTC ✓ 14 92 200 ✓
Purflock 4 °C 176 100 133 ✓ 14 12 17 ✓
Candida tropicalis NCPF 3111 Foam RT 128 TNTC TNTC ✓ 14 143 TNTC ✓
Foam 4 °C 128 71 66 ✓ 14 4 5 ✓
Purflock RT 102 TNTC TNTC ✓ 12 67 146 ✓
Purflock 4 °C 102 77 55 ✓ 12 5 9 ✓
Candida parapsilosis ATCC 22019 Foam RT 158 TNTC TNTC ✓ 7 46 236 ✓
Foam 4 °C 158 58 109 ✓ 7 10 6 ✓
Purflock RT 135 TNTC TNTC ✓ 13 46 121 ✓
Purflock 4 °C 135 120 154 ✓ 13 9 13 ✓
Candida glabrata ATCC 2001 Foam RT 198 96 269 ✓ 16 8 20 ✓
Foam 4 °C 198 71 113 ✓ 16 4 10 ✓
Purflock RT 171 182 260 ✓ 18 21 36 ✓
Purflock 4 °C 171 197 165 ✓ 18 17 23 ✓
TNTC, too numerous to count; RT, room temperature
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morphology of the test microorganism; however, we noticed
that the C. tropicalis NCPF 3111 comprised budding yeast
cells with some hyphal germ tubes and pseudohyphae. All
strains of Candida, including C. auris, were successfully re-
covered by both foam, flocked swabs at room temperature and
at 4 °C, and were found to be complaint with the M40-A2
criteria (Table 1). At time 0, there was no significant differ-
ence between the CFU between the Candida spp. recovered
using both flock and foam swabs at room temperature and at
4 °C; however, after incubation for 24 h and 48 h, the CFU of
the test organisms at room temperature was consistently great-
er than those grown at 4 °C (Fig. 1).
Discussion
Swab transport systems have been used in the maintenance
and management of specimen. In clinical settings, these STSs
aid accuracy and timeliness of diagnosis, which highlights
their importance. The type and quality of swab is also impor-
tant in enabling efficient management of specimen, hence the
development of CLSI M40-A2 standard. Following the pro-
tocols set out by this standard, we investigated and compared
the recovery of Candida spp. using the foam and flocked
Sigma Transwab® swabs. The STS used in this study effi-
ciently recovered and maintained the growth of Candida
spp. including the yeastC. auris, which is of particular interest
to clinicians due to misdiagnosis, link to nosocomial infec-
tions and drug resistance of this pathogen. While the recent
study by Scansen et al. [16] and Gandhi et al. [17] demon-
strated recovery of several Candida spp. and other pathogenic
fungi using other commercial STS based on the M40-A2 pro-
tocol, they did not investigate recovery of C. auris. This study
investigates the recovery and maintenance of different
Candida spp. including C. auris using the M40-A2 protocol.
The M40-A2 does not currently directly address the recovery
of yeasts, with the exception of guidance for urine transport
systems [15]. In this study, we also found that when using the
protocol for adjusting initial inocula, enumeration of the
yeasts was lower than that typically determined from bacteria
cells, which is possibly as a result of the characteristic differ-
ences in sizes of bacteria and yeast; bacteria are smaller in size
Fig. 1 Enumeration of Candida auris on Sabouraud dextrose agar plates
following maintenance at a Sigma Transwab® foam at T0; b Sigma
Transwab® foam at T48 and RT; c Sigma Transwab® foam at T48 and
4 °C; d Sigma Transwab® Purflock® at T0; e Sigma Transwab®
Purflock® at T48 and RT; and f Sigma Transwab® Purflock® at T48
and 4 °C
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0.2 to 2.0 μm in diameter and 2 to 8 μm in length, while the
yeasts range between 2 and 60 μm [18, 19].
Of the Candida spp. used within this study, onlyC. auris is
a known clinical isolate, and in future studies, we recommend
using a panel of clinically pathogens which would better re-
flect the use of STS in clinical situations. However, using the
reference strain cultures is in line with the M40-A2 protocol,
which utilises quality control strains for testing STS. While
the study by Scansen et al. [16] suggested that foam swabs
were superior to flocked swabs particularly when used in
antigen-testing experiments, in our study, we did not notice
any significant differences in the recovery of the Candida spp.
using both swab types. This study provides evidence of recov-
ery of relevant yeasts including organisms of clinical impor-
tance such as the C. albicans and C. auris using the MWE
Sigma Transwab® foam and flock swabs and offers clinical
laboratories confidence to utilise these swabs in maintenance
and transport of pathogenic and non-pathogenic yeasts.
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